SCHEMBL22508259

SCHEMBL22508259

CN[S+]([O-])c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
HSD17B10 Q99714 2/20 0.53
RECQL P46063 1/20 0.53
MAPT P10636 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA12 O43570 1/20 0.48
CA3 P07451 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA5A P35218 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA13 Q8N1Q1 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
ACHE P22303 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.43
MAPK1 P28482 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31518525 0.78 MAPK1 (0.50) ALDH1A1HSD17B10RECQLMAPTCA1
SCHEMBL514043 0.77 HSD17B10 (0.54) ALDH1A1HSD17B10RECQLMAPTCA1
SCHEMBL13359585 0.77 HSD17B10 (0.54) ALDH1A1HSD17B10RECQLMAPTCA1
SCHEMBL1576857 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10RECQLCA1CA2
SCHEMBL2303355 0.76 MAPT (0.48) ALDH1A1HSD17B10RECQLMAPTCA1
SCHEMBL19381979 0.74 MAPK1 (0.46) ALDH1A1HSD17B10RECQLMAPTCA1
SCHEMBL2889414 0.72 ALDH1A1 (0.48) ALDH1A1HSD17B10RECQLCA1CA2
SCHEMBL31518578 0.72 ALDH1A1 (0.54) ALDH1A1HSD17B10RECQLMAPTCA1
SCHEMBL22567 0.72 ALDH1A1 (0.72) ALDH1A1HSD17B10RECQLCA1CA2
SCHEMBL27909482 0.72 ALDH1A1 (0.72) ALDH1A1HSD17B10RECQLCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021155004-A1 STRAD-BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-05 WO disclosed
EP-3539951-B1 NOVEL PYRIMIDINE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER AND INFLAMMATORY DISEASES KOREA RES INST CHEMICAL TECH (KR) 2020-10-07 EP disclosed
CN-1867553-B Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents SCHERING AG 2011-06-08 CN disclosed
CN-1867553-A Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents SCHERING AG (DE) 2006-11-22 CN disclosed